-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$3.6039% Upside
iBio, Inc. Frequently Asked Questions
-
What analysts cover iBio, Inc.?
iBio, Inc. has been rated by research analysts at Loop Capital Markets in the past 90 days.